1st Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$541,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2016 $541,000 Replaced
1st Quarter - Amendment Jul 21, 2017 $540,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership, Biologic Exclusivity

LobbyistCovered position, as disclosed
MICHAEL BRZICA —
HEIDI WILSON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part D Program and Generic Drugs,Medicare reimbursement for biosimilars, The Bipartisan Budget Act of 2015, Fiscal Year 2016 Omnibus Appropriations Act, Covered Outpatient Drugs (CMS-2345-FC)

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New Health and Domestic Policy Advisor in the Office of Senator John McCain; Dep. Asst. Secretary for Legislation at HHS; Dep. Asst. Secretary for Congressional Affairs at DOL; Staff for the House Education and Workforce Committee
MICHAEL BRZICA —
CHRISTIAN OMAR CRUZ —
THOMAS JAMES GARRIGAN New Legislative Correspondent and Associate Legislative Assistant in the Office of Senator Sheldon Whitehouse
CHRISTINE SIMMON —
HEIDI WILSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Inter Partes Review (IPR) process

LobbyistCovered position, as disclosed
HEIDI WILSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

FDA Funding, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2017, The Bipartisan Budget Act of 2015

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New Health and Domestic Policy Advisor in the Office of Senator John McCain; Dep. Asst. Secretary for Legislation at HHS; Dep. Asst. Secretary for Congressional Affairs at DOL; Staff for the House Education and Workforce Committee
MICHAEL BRZICA —
HEIDI WILSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, Innovation for Healthier Americans Initiative, Prescription Drug Cost,H.R. 2841 FAST Generics Act,The Bipartisan Budget Act of 2015, Drug Importation, Risk Evaluation and Mitigation Strategies(REMS),Biologics Price Competition and Innovation Act (BPCIA), Pharmaceutical exclusivity

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN New Health and Domestic Policy Advisor in the Office of Senator John McCain; Dep. Asst. Secretary for Legislation at HHS; Dep. Asst. Secretary for Congressional Affairs at DOL; Staff for the House Education and Workforce Committee
MICHAEL BRZICA —
CHRISTIAN OMAR CRUZ —
THOMAS JAMES GARRIGAN New Legislative Correspondent and Associate Legislative Assistant in the Office of Senator Sheldon Whitehouse
CHRISTINE SIMMON —
HEIDI WILSON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2841 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.